Next Article in Journal
Impact of Temporary Nitrogen Deprivation on Tomato Leaf Phenolics
Next Article in Special Issue
Advances in Carcinogenic Metal Toxicity and Potential Molecular Markers
Previous Article in Journal
MicroRNAs miR-27a and miR-143 Regulate Porcine Adipocyte Lipid Metabolism
Previous Article in Special Issue
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
Int. J. Mol. Sci. 2011, 12(11), 7960-7970; doi:10.3390/ijms12117960
Review

Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?

1,* , 2
, 2
, 1
 and 2,*
Received: 3 August 2011; in revised form: 11 October 2011 / Accepted: 7 November 2011 / Published: 16 November 2011
(This article belongs to the Special Issue Biomarkers 2011)
View Full-Text   |   Download PDF [179 KB, uploaded 19 June 2014]
Abstract: Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disorder of the central nervous system (CNS). Although many advances have been made in the comprehension of its pathogenesis, the etiology is still unknown. The complexity of MS reflects in the extreme variability of the clinical manifestations and clinical course both between and within patients, in addition to immunopathological mechanisms and response to treatment. Several prognostic factors have been suggested in large scale studies, but predictions in individual cases are difficult to make. Cerebrospinal fluid (CSF) biomarkers, such as 14-3-3, tau, and cystatin C are promising sources of prognostic information with a good potential of quantitative measure, sensitivity, and reliability. However, none has shown sufficient reproducibility to be applied in clinical practice. Here we review the current literature addressing the above mentioned biomarkers as MS severity predictors at an early stage.
Keywords: multiple sclerosis; biomarkers; cystatin C; 14-3-3 protein; tau protein multiple sclerosis; biomarkers; cystatin C; 14-3-3 protein; tau protein
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Gajofatto, A.; Bongianni, M.; Zanusso, G.; Benedetti, M.D.; Monaco, S. Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients? Int. J. Mol. Sci. 2011, 12, 7960-7970.

AMA Style

Gajofatto A, Bongianni M, Zanusso G, Benedetti MD, Monaco S. Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients? International Journal of Molecular Sciences. 2011; 12(11):7960-7970.

Chicago/Turabian Style

Gajofatto, Alberto; Bongianni, Matilde; Zanusso, Gianluigi; Benedetti, Maria Donata; Monaco, Salvatore. 2011. "Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?" Int. J. Mol. Sci. 12, no. 11: 7960-7970.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert